Skip to main content
. 2021 Oct 16;398(10309):1417–1426. doi: 10.1016/S0140-6736(21)01431-8

Table 2.

Illness presentation of randomised participants

Placebo group (n=211) Antibiotics group (n=221)
Baseline severity* 1·6 (0·3) 1·6 (0·3)
Cough severity 1·9 (1·1) 2·0 (1·1)
Duration of symptoms rated moderately bad or worse, days 6 (3–10) 5 (3–10)
Prespecified subgroups
Abnormal chest signs 72 (34%) 78 (35%)
Sputum or chest rattle 155/210 (74%) 170/219 (78%)
Fever during illness 161 (76%) 177 (80%)
Unwell according to physician 141 (67%) 143 (65%)
Shortness of breath 95 (45%) 104 (47%)
Oxygen saturation low (<95%) 9/166 (5%) 13/170 (8%)
STARWAVe40§
Very low risk 110 (52%) 123 (56%)
Normal risk 95 (45%) 94 (43%)
High risk 6 (3%) 4 (2%)
Physician rating of unwell 5·5 (1·7) 5·5 (1·6)
Parent rating of unwell 3·8 (1·7) 3·7 (1·7)
Temperature, °C, mean (SD; n) 37·3 (0·8; n=208) 37·2 (0·8; n=220)
Oxygen saturation, %, mean (SD; n) 97·3 (1·6; n=166) 97·3 (1·6; n=170)
Heart rate, beats per min, mean (SD; n) 112·0 (20·3; n=207) 111·8 (17·9; n=213)
Respiratory rate, breaths per min, mean (SD; n) 24·8 (6·8; n=198) 25·4 (7·1; n=213)
Tachypnoea 25/198 (13%) 30/213 (14%)
Capillary refill >3 s 3 (1%) 2 (1%)
Consciousness
Normal 203 (96%) 214 (97%)
Irritable 8 (4%) 5 (2%)
Drowsy 0 1 (<1%)
Ill appearance 48 (23%) 47 (21%)
Number of days unwell before seeing general practitioner, median (IQR; n) 5 (3–9; n=108) 5 (3–7; n=119)
Treated with over-the-counter medication 105/111 (95%) 107/121 (88%)

Data are mean (SD), median (IQR), n (%), or n/N (%), unless otherwise specified.

*

Scale of 1–4 as follows: 1=none, 2=mild, 3=moderate, and 4=severe.

Includes wheeze, stridor, grunting, nasal flaring, intercostal or subcostal recession, crackles or crepitations, and bronchial breathing.

Dichotomised at ≥5.

§

STARWAVe prediction rule for hospital admission (short illness, temperature, age, recession, wheeze, asthma, and vomiting).

Scale of 0–10.

Data missing for one person in the antibiotics group.